• Skip to main content
  • Skip to footer

Pachyonychia Congenita Project

Fighting for a cure. Connecting & helping patients. Empowering Research.

Donate
VIEW MENUMENU
  • Pachyonychia Congenita
        • What Is Pachyonychia Congenita?
          • Could I Have PC?
          • Getting Diagnosed
          • Genetics
          • Image Library
          • Glossary
          • Brochures
          • Patient Stories
        • Patient Registry (IPCRR)
          • Patient Registry Data
        • Understanding my Genetic Testing Results
          • K6a-pEDD-PC
          • K6b-pEDD-PC
          • K6c-pEDD-PC
          • K16-pEDD-PC
          • K17-pEDD-PC
          • Non-PC Palmoplantar EDDs
        • Managing and Caring For PC
          • Tips and Tools
          • Living With PC
          • PC & Children
          • Working With Medical Professionals
          • Family & Friends: How To Help
          • Video Library
  • For Professionals
        • For Professionals
          • International PC Consortium
          • Pharmaceutical Partners
          • Refer a Patient
          • Patient Registry (IPCRR)
            • Patient Registry Data
            • Non-PC Palmoplantar EDDs
          • Advocacy Partners
        • PC Research
          • Apply for a Grant
          • Awarded Grants
          • Published Research Articles
          • Clinical Trials
        • Patient Voices
          • Quality of Life
          • Patient Stories
          • Patient-Focused Drug Development Meeting
  • Ways To Give
        • Ways You Can Give
          • Donate
          • Donate Just Giving UK
          • Steady Relief Circle
          • Donor-Advised Fund
          • Giving Stock
          • Legacy Society
        • Raise Awareness
          • How You Can Help
          • Fundraising Ideas
          • Share Your Story
          • PC Advocates
          • Volunteer
        • Our Supporters
  • News & Events
        • News
          • Current Newsletter
          • Newsletter Archives
          • Sign up for our Newsletter
        • Events
          • Patient Support Meetings
          • IPCC Meetings
          • Video Library
  • About Us
        • About PC Project
        • Medical and Scientific Advisory Board
        • Financial & Legal Information
        • Contact Us

K6a-pEDD-PC

ABOUT THE KRT6A GENE

The KRT6A gene provides instructions for making a protein called keratin 6a or K6a. Keratins are a group of tough, fibrous proteins that form the structural framework of certain cells, particularly cells that make up the skin, hair, nails, and similar tissues. Keratin 6a is produced in the nails, the skin on the palms of the hands and soles of the feet, and the oral mucosa that lines the inside of the mouth.

Keratin 6a partners with a similar protein, keratin 16, to form molecules called keratin intermediate filaments. These filaments assemble into dense networks that provide strength and resilience to the skin, nails, and other tissues. Networks of keratin filaments protect these tissues from being damaged by friction and other everyday physical stresses. Keratin 6a is also among several keratins involved in wound healing.

Mutations in the KRT6A gene responsible for PC-K6a1 change the structure of keratin 6a, preventing it from working effectively with keratin 16 and interfering with the assembly of the keratin intermediate filament network. Without this network, skin cells become fragile and are easily damaged, making the skin less resistant to friction and minor trauma. Even normal activities, such as walking can cause skin cells to break down, resulting in the formation of painful blisters and calluses. Additionally, fragile skin cells may abnormally produce more keratin in response to damage, which makes the skin problems worse.

Defective keratin 6a also disrupts the growth and function of cells in the nails and oral mucosa, which explains why the signs and symptoms of PC-K6a also affect these tissues. (Adapted from http://ghr.nlm.nih.gov/gene/KRT6A.)

1PC classification replacing PC-1 and PC-2 classification. See W. H. McLean et al. The
phenotypic and molecular genetic features of pachyonychia congenita.
J Invest Dermatol. 2011;131(5):1015-7.

To learn how many others have mutations in the same gene — or even the same specific mutation — visit the PC data page, which provides detailed information on those with PC and the various mutations.


Observations on PC-K6a from the IPCRR

Patients with mutations in PC-K6a experience painful plantar keratoderma as the most challenging feature of PC and are eager to find relief, especially for the associated pain.

  • The condition is usually evident at birth, often presenting with 20/20 nail dystrophy.
  • PC-K6a nails may be extremely thickened or may not grow out completely.
  • Plantar keratoderma and pain is experienced by nearly 100% of PC-K6a patients by age 10. Pain levels for PC-K6a patients are often from 6 to 10 on a 0 to 10 scale.
  • Leukokeratosis in oral mucosa is often present very early, and PC-K6a infants are often misdiagnosed with thrush.
  • In children with PC-K6a, several unique conditions occur that are not typically seen in other types of PC:
    • Infants may have feeding/sucking problems with crying after a few seconds of sucking. This is solved by an enlarged hole in the nipple or use of syringe for feeding, or thickened formula. After initial crying, feeding usually can resume. Some infants undergo efforts by ENTs to remove the leukokeratosis which may make the condition worse and is not the cause of the feeding issue.
    • Follicular hyperkeratosis (FHK) is problematic for children up to age 12 or so and lessens after that time. It occurs at areas of friction on elbows, knees, waist, etc.
    • Extreme pain lasting 15 to 25 seconds occurs with first bite or first swallow, which we believe may be related to salivary glands is experienced by children ages 4 to 12 and lessens after that. This is often misdiagnosed as an ‘ear’ problem.

IPCRR Data for PC-K6a


Plantar Keratoderma86%
Always (never goes away)79%
Sometimes (clears up at times)5%
Seldom (feet usually clear)1%
Plantar Keratoderma – Onset
Birth or less than 1 year18%
1 to 4 years old56%
5 to 14 years old25%
15 years and over2%
Plantar Pain95%
Often require medications for pain21%
Very painful, but do not use medications35%
Somewhat painful25%

Palmar Keratoderma67%
Always (never goes away)27%
Sometimes (clears up at times)12%
Seldom (hands usually clear)16%

Toenail Dystrophy98%
all 10 toenails thickened91%
7-9 toenails thickened3%
4-6 toenails thickened2%
1-3 toenails thickened2%
Toenails – Onset
Birth or less than 1 year86%
1 to 4 years old12%
5 to 14 years old2%
15 years and over0%

Fingernail Dystrophy97%
all 10 toenails thickened86%
7-9 toenails thickened4%
4-6 toenails thickened6%
1-3 toenails thickened1%
Fingernails – Onset
Birth or less than 1 year88%
1 to 4 years old11%
5 to 14 years old1%
15 years and over1%

Oral Leukokeratosis86%
Cysts58%
Follicular Hyperkeratosis48%
Natal or Prenatal Teeth5%

Data from 2021 Sample Size N=412


Footer

PC Project logo in white
PACHYONYCHIA CONGENITA PROJECT

P.O. Box 17850
Holladay, UT 84117

info@pachyonychia.org

801-987-8758

EIN 68-0567493

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Sign up for our Newsletter

Loading

Support PC Project

There are many ways you can help improve the lives of those who suffer from Pachyonychia Congenita.

Learn More
  • Contact Us
  • About Us
  • Donate
  • Patient Registry

Copyright © 2026 PC Project. All rights reserved. Pachyonychia Congenita Project is a 501(c)(3) under federal tax guidelines. Using this site means you accept its terms as outlined in the disclaimer and privacy policy.